| Identification | More | [Name]
(3R,4S)-tert-Butyl 2-oxo-4-phenyl-3-(triethylsilyloxy)azetidine-1-carboxylate | [CAS]
149198-47-0 | [Synonyms]
(3R,4S)-2-Oxo-4-phenyl-3-[(triethylsilyl)oxy]-1-azetidinecarboxylic acid 1,1-dimethylethyl ester
(3R,4S)-TERT-BUTYL 2-OXO-4-PHENYL-3-(TRIETHYLSILYLOXY)AZETIDINE-1-CARBOXYLATE
DOCETAXEL SIDE CHAIN NO 2
(3r,4s)-1-Azetidine Carboxylic Acid-2-Oxo-4-Phenyl-3-[(Triethylsilyl)Oxy]-1,1-Dimethyl Ethyl Ester
(3R,4S)-1-AZETIDINECARBOXYLIC ACID 2-OXO-4-PHENYL-3-[(TRIETHYLSILY)OXY]-1,1-DIMETHYLETHYL ESTER
(3R,4S)-1-Azetidinecarboxylicacid-2-Oxo-4-Phenyl-3-[(Triethylsily)Oxy]-1,1-DimethylethylEsterCasNo.
(3R,4S)-1-TERT-BUTOXYCARBONYL-3-TRIETHYLSILYLOXY-4-PHENYL-2-AZETIDINONE
(3R,4S)-1-Azetidinecarboxylic
(3R,4S)-1-t-butoxycarbonyl-3-triethylsilyloxy-4-phenyl-2-azetidinone
(3R,4S)-1-t-Boc-3-[(triethylsilyl)oxy]-4-phenyl-2-azatidinone
(3R-cis)-2-Oxo-4-phenyl-3-[(triethylsilyl)oxy]-1-azetidinecarboxylic Acid 1,1-Dimethylethyl Ester | [Molecular Formula]
C20H31NO4Si | [MDL Number]
MFCD08273948 | [Molecular Weight]
377.55 | [MOL File]
149198-47-0.mol |
| Chemical Properties | Back Directory | [Appearance]
Syrup | [Boiling point ]
463.1±45.0 °C(Predicted) | [density ]
1.07 | [storage temp. ]
Sealed in dry,2-8°C | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Oil | [pka]
-4.79±0.60(Predicted) | [color ]
Colourless | [Stability:]
Moisture Sensitive | [InChI]
InChI=1S/C20H31NO4Si/c1-7-26(8-2,9-3)25-17-16(15-13-11-10-12-14-15)21(18(17)22)19(23)24-20(4,5)6/h10-14,16-17H,7-9H2,1-6H3/t16-,17+/m0/s1 | [InChIKey]
LHTDXUKSFSMGCA-DLBZAZTESA-N | [SMILES]
N1(C(OC(C)(C)C)=O)[C@@H](C2=CC=CC=C2)[C@@H](O[Si](CC)(CC)CC)C1=O | [CAS DataBase Reference]
149198-47-0(CAS DataBase Reference) |
| Questions And Answer | Back Directory | [Application]
(3R,4S)-3-(triethylsiloxy)-4-phenyl-2-oxo-azacyclobut-1-carboxylic acid tert-butyl ester is an organic synthesis intermediate and a pharmaceutical intermediate that can be used in laboratory research and development processes as well as in chemical and pharmaceutical synthesis processes. |
|
|